Comparative clinical study of two omega-3 supplements in the form of fish oil and algae oil with regard to their influence on periodontitis treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033808

Enrollment

Registered

2024-04-15

Start date

2024-05-13

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K05.3

Interventions

Group 1: N=20-25 There are 12 weeks between the examination times T1 and T2. Omega-3, 2000mg/day p.o. (oil) for 12 weeks (Omega-3 total oil from Norsan, 8ml/day) Patients with chronic periodontitis ar

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with chronic periodontitis - Information sheet signed by the patient and declaration of consent for the study

Exclusion criteria

Exclusion criteria: - Smokers - Patients undergoing anticoagulant therapy - Patients already taking omega-3 supplements

Design outcomes

Primary

Measure	Time frame
Periodontal parameters in patients with chronic periodontitis, determined before therapy (T1) and after 12 weeks (T2). PD- probing depths CAL - Clinical Attachment Level PI - Plaque Index BOP - Bleeding on probing (bleeding on probing) HS Omega-3 Index	—

Secondary

Measure	Time frame
Various questionnaires will be developed to record clinical data and patients' answers to predefined questions at T1. These include - Patient information sheet and informed consent form for the study - General medical history form - Nutrition questionnaire	—

Countries

Germany

Contacts

Public ContactRegina Busch-Greif

Hochschule Anhalt

rbgreif@web.de+49 170 4142119

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026